Dermata Therapeutics Warrant Stock Price on December 16, 2024
| DRMAW Stock | USD 0.01 0 16.94% |
If you're considering investing in Dermata Stock, it is important to understand the factors that can impact its price. As of today, the current price of Dermata Therapeutics stands at 0.01, as last reported on the 20th of December, with the highest price reaching 0.01 and the lowest price hitting 0.01 during the day. Dermata Therapeutics is out of control given 3 months investment horizon. Dermata Therapeutics secures Sharpe Ratio (or Efficiency) of 0.17, which denotes the company had a 0.17% return per unit of risk over the last 3 months. We were able to analyze twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.99% are justified by taking the suggested risk. Use Dermata Therapeutics Downside Deviation of 22.69, mean deviation of 12.08, and Coefficient Of Variation of 1396.23 to evaluate company specific risk that cannot be diversified away.
At this time, Dermata Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Capital Stock is likely to climb to 655.46 in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 7.2 M in 2024. . At this time, Dermata Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to climb to 0.29 in 2024, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0). Dermata Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Dermata |
Sharpe Ratio = 0.1731
| Best Portfolio | Best Equity | |||
| Good Returns | DRMAW | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 17.26 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.99 actual daily | 59 59% of assets have lower returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Dermata Therapeutics is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dermata Therapeutics by adding it to a well-diversified portfolio.
Book Value 24.251 | Shares Float 1.3 M | Shares Short Prior Month 1.2 K | Earnings Share (2.16) | Shares Short 1.2 K |
Dermata Therapeutics Main Headline on 16th of December 2024
Dermata Receives Approval from FDA for the Proprietary Name ... by finance.yahoo.com
- Xyngari is currently being studied in Phase 3 for the treatment of acne, with topline results from the first Phase 3 STAR-1 study expected in March 2025 - SAN DIEGO, CA ACCESSWIRE December 16, 2024 Dermata Therapeutics, Inc. ...
Dermata Therapeutics Valuation on December 16, 2024
It is possible to determine the worth of Dermata Therapeutics on a given historical date. On December 16, 2024 Dermata was worth 0.0101 at the beginning of the trading date compared to the closed value of 0.0124. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Dermata Therapeutics stock. Still, in general, we apply an absolute valuation method to find Dermata Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Dermata Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Dermata Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.01 | 0.01 | 0.01 | 0.01 | 10.00 | |
12/16/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 420.00 |
| 0.01 | 0.01 | 0.01 | 0.01 | 6,100 |
| Backtest Dermata Therapeutics | | | Dermata Therapeutics History | | | Dermata Therapeutics Valuation | Previous | Next |
Dermata Therapeutics Trading Date Momentum on December 16, 2024
| On December 17 2024 Dermata Therapeutics Warrant was traded for 0.01 at the closing time. The highest daily price throughout the period was 0.01 and the lowest price was 0.01 . The daily volume was 6.1 K. The net trading volume on 12/17/2024 added to the next day price increase. The overall trading delta to closing price of the next trading day was 16.94% . The overall trading delta to current closing price is 0.00% . |
Dermata Therapeutics Fundamentals Correlations and Trends
By evaluating Dermata Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Dermata Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Dermata financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Dermata Therapeutics Stock history
Dermata Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Dermata is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Dermata Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Dermata Therapeutics stock prices may prove useful in developing a viable investing in Dermata Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 195 K | 185.2 K |
Dermata Therapeutics Stock Technical Analysis
Dermata Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Dermata Therapeutics Period Price Range
Low | December 20, 2024
| High |
0.00 | 0.00 |
Dermata Therapeutics Warrant cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Dermata Therapeutics December 20, 2024 Market Strength
Market strength indicators help investors to evaluate how Dermata Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dermata Therapeutics shares will generate the highest return on investment. By undertsting and applying Dermata Therapeutics stock market strength indicators, traders can identify Dermata Therapeutics Warrant entry and exit signals to maximize returns
Dermata Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Dermata Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Dermata Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Dermata to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0665 | |||
| Jensen Alpha | 1.61 | |||
| Total Risk Alpha | 0.8822 | |||
| Sortino Ratio | 0.0654 | |||
| Treynor Ratio | (0.33) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Dermata Stock Analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.